Your session is about to expire
← Back to Search
Chemotherapy for Breast Cancer
Study Summary
This trial is comparing two different chemotherapy regimens to see which is more effective in treating patients with stage I-III breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 3871 Patients • NCT00041119Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had surgery to remove breast cancer and affected lymph nodes.My tumor is not HER2 positive.I haven't had cancer in the past 5 years, except for certain skin cancers or early-stage cervical or breast cancer.My cancer is at an early or mid-stage and can be operated on.I know my cancer's estrogen and progesterone receptor status.My tumor is smaller than 1 cm and doesn't meet certain criteria.My tumor is HER2/neu-positive.I have breast cancer in both breasts, diagnosed within a month of each other, and the more advanced tumor meets the study criteria.My breast cancer is confirmed and not spread beyond stage III.My tumor is larger than 2 cm or larger than 1 cm with specific features.My cancer has not spread to my lymph nodes and my tumor is at least 1 cm with high-risk features or larger than 2 cm.My cancer has not spread to nearby tissues.My breast cancer has not spread to underarm or breast nodes.My breast cancer has spread to my lymph nodes.
- Group 1: Arm I
- Group 2: Arm III
- Group 3: Arm V
- Group 4: Arm II
- Group 5: Arm IV
- Group 6: Arm VI
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the dangers associated with the AC regimen?
"The AC regimen has been studied in multiple Phase 3 trials, so it received a score of 3."
What does the existing research say about AC therapy?
"The AC regimen was first explored in 1997 at the Spectrum Health Hospital - Butterworth Campus. In the 24 years since, there have been 2495 completed studies. Currently, there are 1780 clinical trials in progress, many of which are based in South Bend, Indiana."
What type of illness does AC regimen usually target?
"The AC regimen is a course of treatment that is not only effective for leukemia, but also for other conditions such as locally advanced non-small cell lung cancer, metastatic bladder cancer, and lung cancers."
Are there still unfilled positions in this research project?
"According to the listing on clinicaltrials.gov, this study is no longer recruiting patients. The trial was first posted on November 1st, 2003 and was last edited on January 19th, 2022. There are 4457 other trials that are still recruiting patients."
Share this study with friends
Copy Link
Messenger